4,4'-(Propane-2,2-diyl)bis(2-bromophenol), 95%, 1g

Methyl 3-Bromopyrazine-2-carboxylate, 97.0%, 10g

Tert-butyl (S)-2-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate, 98%, 1g

4-Chloro-2-cyclopropyl-5-iodo-6-methylpyrimidine, 95%, 250mg

GC capillary column ROTI®Cap-1, 60 m, 0.25 mm, 0.50 µm, 1 Piece(s)

2-Acetylbenzothiophene, 97.0%, 100g

Freezing point standard, 577 m°H (-0.557 °C), 250 ml, plastic bag.

N-(2,4-Dimethoxybenzyl)-5-fluoro-N-(6-fluoropyridin-2-yl)-2-oxo-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 97%, 50mg

tert-Butyl N-[3-(aminomethyl)oxetan-3-yl]carbamate, 97%, 250mg

(Butylthio)acetic acid, 250mg

1-Boc-4-Formyl-4-methylpiperidine, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-carbamoylphenyl)propanoic acid, 97%, 25g

Quinoxaline>99.0%(GC)25g